InveniAI® Corporation, a Guilford-based global leader in pioneering the application of artificial intelligence and machine learning to transform innovation across healthcare and other industries, was featured in a recent article in The Guardian.

InveniAI has leveraged its AlphaMeldTM platform for numerous collaborations such as Alexion, Axcella Health, Centrexion, and most recently Kyowa Hakko Kirin.

“We believe that our artificial intelligence and machine learning platform can make a significant impact in helping our partners create breakthrough treatments with a high probability of success,” said Krishnan Nandabalan, Ph.D., CEO and President.